| [1] | Ravelli A, Martini A. Juvenile idiopathic arthritis[J]. Lancet,2007,369(9563):767-778. | 
																													
																							| [2] | Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features[J]. Arthritis Care Res (Hoboken),2011,63(4):465-482. | 
																													
																							| [3] | Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials[J]. JAMA,2006,295(19):2275-2285. | 
																													
																							| [4] | 吴瑞萍, 胡亚美, 江载芳, 等. 实用儿科学[M]. 7版. 北京: 人民卫生出版社,2002:738. | 
																													
																							| [5] | 俞蕙, 朱启镕. 水痘-带状疱疹病毒感染的研究现状[J]. 中国疫苗和免疫,2001,7(2):119-122. | 
																													
																							| [6] | Katsimpardi K, Papadakis V, Pangalis A, et al. Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment[J]. Support Care Cancer,2006,14(3):277-284. | 
																													
																							| [7] | Cimaz R, Von SA, Hofer M. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease[J]. Swiss Med Wkly,2012,142(19):w13582. | 
																													
																							| [8] | Ravelli A, Varnier GC, Oliveira S, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis[J]. Arthritis Rheum,2014,63(1):267-275. | 
																													
																							| [9] | Modesto C, Woo P, Garcia-Consuegra J, et al. Systemic onset juvenilechronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis[J]. Clin Exp Rheumatol,2011,19(2):211-217. | 
																													
																							| [10] | Heininger U, Seward JF. Varicella[J]. Lancet,2006,368(9544):1365- 1376. | 
																													
																							| [11] | Aebi C, Fischer K, Gorgievski M, et al. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data[J]. Vaccine,2001,19(23-24):3097-3103. | 
																													
																							| [12] | Woerner A, Ritz N. Infections in children treated with biological agents[J]. Pediatr Infect Dis J,2013,32(3):284-288. | 
																													
																							| [13] | Wiegering V, Schick J, Beer M, et al. Varicella-zoster virus infections in immunocompromised patients--a single centre 6-years analysis[J]. BMC Pediatr,2011,11:31. | 
																													
																							| [14] | Bracaglia C, Buonuomo PS, Tozzi AE, et al. Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4 years of age J]. J Rheumatol,2012,39(6):128790. | 
																													
																							| [15] | Heininger U, Braun-Fahrlander C, Desgrandchamps D, et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity[J]. Pediatr Infect Dis J,2001,20(8):75-78. | 
																													
																							| [16] | Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents[J]. Eur J Pediatr,2005,164(6):366-370. | 
																													
																							| [17] | Choo PW, Donahue JG, Manson JE, et al. The epidemiology of varicella and its complications[J]. J Infect Dis,1995,172(3):706-712. | 
																													
																							| [18] | Galil K, Brown C, Lin F, et al. Hospitalizations for varicella in the United States, 1988 to 1999[J]. Pediatr Infect Dis J,2002,21(10):931-935. | 
																													
																							| [19] | Guess HA, Broughton DD, Melton 3rd LJ, et al. Population-based studies of varicella complications[J]. Pediatrics,1986,78(4 Pt 2):723-727. | 
																													
																							| [20] | Etzioni A, Eidenschenk C, Katz R, et al. Fatal varicella associated with selective natural killer cell deficiency[J]. J Pediatr,2005,146(3):423-425. | 
																													
																							| [21] | Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: seventy-seven cases[J]. Pediatrics,1975,56(3):388-397. | 
																													
																							| [22] | 江载芳, 申昆玲, 沈颖. 诸福堂实用儿科学[M]. 8版. 2015:740-741. |